Guardant Health is Conquering Cancer with Data. We’re developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors. Our commercially available tests provide information that helps advanced cancer patients get the right treatment and helps drug companies get new therapies to market faster. To learn more about Guardant Health, visit www.guardanthealth.com.
Guardant360 CDx is our commercially available test and is the first FDA-approved comprehensive liquid biopsy for all advanced solid tumors. To learn more about Guardant360 CDx, visit: www.guardant360CDx.com
Virtual Drop In
March 6th, 7:45 a.m. – 12:00 p.m. CST
Click here to join the zoom meeting